UCANACT
Utrecht, NetherlandsFounded 2025
UCANACT is a digital assistive technology paired with wearables or implants to give motor-disabled individuals control over digital devices.
- Founded
- 2025
- Employees
- 1–10
reccy insights
UCANACT’s latest reported milestone is its €800,000 pre-seed round, announced on Sep 15, 2026 and equivalent to $922,932. TTT-AI and Utrecht Health Seed Fund are named as lead investors for the round. The company was founded in 2025 in Utrecht, Netherlands, and is developing digital assistive technology for people with severe motor disabilities. Its stated approach pairs a system with a wearable or brain-computer implant to translate a user’s intent into digital actions, with the aim of enabling control of personal devices and connection with caregivers and family. The current leadership includes co-founder and CEO Julia Berezutskaya, whose role began in October 2025, and co-founder and CSO Nick Ramsey, whose role began in 2025. The recent funding provides a clear financing milestone, but there is not enough information to assess how the proceeds are being deployed or whether the technology has reached broad clinical or commercial use.
Written by reccy's AI from company sites, press and funding records · updated Oct 2026
Technology & products
- UCANACT assistive technology
A digital assistive technology system designed to pair with a wearable or brain-computer implant and translate user intent into control of digital devices.
About UCANACT
- Products
- UCANACT assistive technology
- Leadership
- Julia Berezutskaya, Co-Founder and CEONick Ramsey, CSO and Co-Founder
- Focus areas
- Assistive Technology, health care, medical device, neuroscience
- Headquarters
- Utrecht, Netherlands
- Founded
- 2025
- Employees
- 1–10